Rtw Investments »

Irhythm Technologies shares owned by Rtw Investments

Quarter-by-quarter ownership of Irhythm Technologies (IRTC) shares owned by Rtw Investments from 13F filings

Historical chart of Rtw Investments investment in Irhythm Technologies

Tip: Access up to 7 years of quarterly data

All positions including Irhythm Technologies held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Irhythm Technologies by Rtw Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $210M 1.2M 177.44

More positions owned by Rtw Investments

Madrigal Pharmaceuticals (MDGL)
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Argenx Se Sponsored Adr (ARGX)
Protagonist Therapeutics (PTGX)
Natera (NTRA)
RadNet (RDNT)
Tarsus Pharmaceuticals (TARS)
Cogent Biosciences (COGT)
Penumbra (PEN)
Irhythm Technologies (IRTC)
Apogee Therapeutics (APGE)
Apellis Pharmaceuticals (APLS)
ACADIA Pharmaceuticals (ACAD)
Establishment Labs Holdings Ord (ESTA)

View all positions for Rtw Investments

Top funds holding Irhythm Technologies

Vanguard Group
BlackRock
Sands Capital Management
Artisan Partners Limited Partnership
Capital Research Global Investors
Rtw Investments
Geode Capital Management
Ubs Global Asset Management Americas
State Street Corporation
William Blair $ Company
Eventide Asset Management
Holocene Advisors
Hanna Zanoni
FMR
Arrowstreet Capital, Limited Partnership

View all funds holding Irhythm Technologies